Gregory Rak
2PUBLICATIONS
8CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Aug 18, 2022
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.Kent Thudium, Mark Selby, Julie A Zorn
|Feb 16, 2020
Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS-986260, mitigates class-based cardiovascular toxicity in dogs but not rats.Gregory D Rak, Melvin R White, Karen Augustine-Rauch
Pageof 1

